• Emmaus Announces Initiation of its Diverticulosis Study americanpharmaceuticalreview
    July 09, 2019
    Emmaus Life Sciences announced the screening of the first patient for the company's Pilot/Phase 1 study on the treatment of diverticulosis with pharmaceutical-grade L-glutamine (PGLG).
PharmaSources Customer Service